StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.33−0.19 (-12.76%)

Close on Nov 18, 2026Market cap $21.75MP/E –Yield –

Cellyan Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2026 it was $13.43M, down 33.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 31, 2026$13.43M-33.9%
FY2025Mar 31, 2025$20.31M+21.7%
FY2024Mar 31, 2024$16.69M+32.9%
FY2023Mar 31, 2023$12.56M–

More Cellyan Biotechnology figures

See a number that looks wrong?